Yahoo! Finance: ZGEN News

Synthetic platelets quickly stem bleeding - study (at Reuters)

Wed, 16 Dec 2009 21:29:55 Etc/GMT

ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)

Tue, 15 Dec 2009 21:04:51 Etc/GMT

ZymoGenetics shares fall on regulatory delay (AP)

Tue, 15 Dec 2009 18:47:10 Etc/GMT

Shares of ZymoGenetics Inc. dipped Tuesday after the company said additional studies are likely needed to gain European regulatory approval of its only marketed product, Recothrom.

ZymoGenetics marketing partner pulls back in Europe (at bizjournals.com)

Mon, 14 Dec 2009 18:05:26 Etc/GMT

ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)

Mon, 14 Dec 2009 11:01:47 Etc/GMT

ZymoGenetics claims court win versus King (at bizjournals.com)

Thu, 10 Dec 2009 23:05:19 Etc/GMT

UPDATE - Zymogenetics says court denies King Pharma motion (at Reuters)

Thu, 10 Dec 2009 20:55:02 Etc/GMT

ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)

Thu, 10 Dec 2009 19:58:52 Etc/GMT

ZGEN Inks Licensing Deal (Zacks.com)

Tue, 8 Dec 2009 13:02:22 Etc/GMT

ZYMOGENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a (EDGAR Online)

Tue, 8 Dec 2009 11:03:19 Etc/GMT

Novo Nordisk Licenses IL-21 mAb and Patent Rights to IL-21 Antibodies from ZymoGenetics (Business Wire)

Tue, 8 Dec 2009 07:00:00 Etc/GMT

SEATTLE & COPENHAGEN----Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.

UPDATE - ZymoGenetics cuts jobs, stops immunology research (at Reuters)

Thu, 3 Dec 2009 23:05:34 Etc/GMT

ZYMOGENETICS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (EDGAR Online)

Thu, 3 Dec 2009 22:02:23 Etc/GMT

Somaxon, Kimber Resources: Midday Volume Plays (at TheStreet.com)

Mon, 30 Nov 2009 18:17:58 Etc/GMT

ZymoGenetics to Webcast Presentation at the Piper Jaffray Healthcare Conference (Business Wire)

Tue, 24 Nov 2009 11:00:00 Etc/GMT

SEATTLE----ZymoGenetics, Inc. announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the Piper Jaffray Healthcare Conference in New York City on Wednesday, December 2, 2009 at 8:30 a.m.

Former ZymoGenetics CEO named to Immune Design posts (at bizjournals.com)

Mon, 23 Nov 2009 17:05:17 Etc/GMT

BUY OR SELL-Will ZymoGenetics shares start to bleed? (at Reuters)

Thu, 19 Nov 2009 15:40:29 Etc/GMT

Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com (GlobeNewswire)

Thu, 12 Nov 2009 11:50:00 Etc/GMT

DALLAS -- StockPreacher.com announces an investment report featuring ZymoGenetics Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

ZYMOGENETICS INC Financials (EDGAR Online Financials)

Wed, 11 Nov 2009 14:05:18 Etc/GMT

UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector (Wall Street Transcript)

Tue, 10 Nov 2009 19:59:00 Etc/GMT

67 WALL STREET, New York - November 10, 2009 - The Wall Street Transcript has recently published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.